Drug Development and Safety

The Drug Development and Safety team at Accelsiors CRO is responsible for ensuring the safety and efficacy of clinical drug candidates. This team, comprising Pharmacovigilance Scientists, Legal Counsel, Clinical Trial Assistants, Patient Recruitment and Retention Associates, as well as senior leadership such as the Vice President of Late Stage Development and the Director of Translational Science, collaborates to monitor and evaluate drug safety data, manage regulatory compliance, optimize patient recruitment, and oversee the transition from early to late-stage development. Their collective efforts ensure that clinical trials are conducted with the highest standards of quality and safety, aiding in the successful development of new therapies.